Cloudstone Venture Capital

Overview

Cloudstone Venture Capital is an early-stage venture capital firm specializing in healthtech investments. Founded in 2016, the firm has been operating Cloudstone Venture Fund I, which invests in technology startups including Healthtech, AI, and new technologies. Building on Fund I's success, Cloudstone has expanded its General Partner (GP) team for Fund II, focusing exclusively on Healthtech. The GPs' extensive experience and broad networks bring unique advantages to the firm. Cloudstone reviews more than 300 companies for investment each year, leveraging robust proprietary deal sourcing through direct and indirect relationships with entrepreneurs in unique medical, academic, and technology groups such as Biodesign and the Fogarty Institute. Their GP team brings varied leadership experience, having been entrepreneurs and served as board members, chairs, professors, CEOs, institute and incubator heads, in profit and non-profit organizations. In addition to providing capital to their portfolio startup companies, Cloudstone offers advice and connections. They assist their portfolio companies with FDA 510k compliance, follow-on financing, and strategic investment/partnering. They connect portfolio companies to various resources to help them grow. Based on Healthtech trends and the Cloudstone team's complementary expertise, skills, and relationships, Fund II focuses on four verticals: Medical Devices, Bio Pharma, AI and Digital Health, and Genomics & Personalized Medicine. These are Fund I areas of investment, where the team sees the greatest opportunity for outsized impact and return.

Investment Focus

• Innovative healthtech solutions
• Strong management teams
• Scalable business models
• Potential for significant market impact

Portfolio Companies